期刊文献+

病理性瘢痕与正常皮肤的蛋白质组学研究 被引量:5

Proteomic analysis between pathological scars and normal skin
下载PDF
导出
摘要 目的:通过比较病理性瘢痕与正常皮肤组织的蛋白质组表达差异,寻找和筛选出病理性瘢痕形成机制中的特异蛋白质。方法:运用蛋白质组学技术,对8例瘢痕疙瘩、8例增生性瘢痕患者的组织和3例正常皮肤组织进行差异双向电泳(2D-DIGE),选择差异蛋白质斑点,进行MALDI-TOF/TOF质谱分析和生物信息学分析。结果:成功建立病理性瘢痕和正常皮肤组织的双向凝胶电泳图谱,瘢痕疙瘩、增生性瘢痕和正常皮肤组织凝胶电泳图谱中平均蛋白质斑点数分别为2 978、2 975和3 053。与正常皮肤组织相比,我们对瘢痕疙瘩和增生性瘢痕中差异超过4倍的斑点进行质谱分析和数据库检索,共鉴定出36种不同蛋白,包括:瘢痕疙瘩和增生性瘢痕表达相同的16种蛋白,其中上调蛋白8种,下调蛋白8种;只在瘢痕疙瘩中表达的有11种不同蛋白,其中上调9种,下调2种;只在增生性瘢痕中表达的有9种不同蛋白,其中上调4种,下调5种。结论:蛋白质组学较好地显示了病理性瘢痕与正常皮肤组织间的蛋白质表达差异;进一步研究鉴定出的差异蛋白质,有可能对揭示病理性瘢痕形成机制提供新的思路。 AIM: To investigate and screen the sensitive proteins in the formation mechanism of p athological scars by comparing the results of differential proteomic analysis be tween pathological scars and normal skin.METHODS: Two-dimensional gel electrophoresis was used to detect the protein expression pr ofiles in 8 keloid patients,8 hypertrophic scar patients and 3 matched normal s kin patients.The proteins that showed differential expression of over 4-fold ch ange were cut and analyzed by MALDI-TOF/TOF mass spectrometry. RESULTS: A two-dimensional protein profiling comparison between pathological scars and no rmal skin was successfully established.On average,2 978 spots in keloid,2 975 spots in hypertrophic scar and 3 053 spots in normal skin were identified using gel analysis software.Compared with normal skin,there were totally 36 differe ntially-expressed proteins in keloid and hypertrophic scar identified from the s pots of over 4-fold change,including 16 proteins in both keloid and hypertrophi c scar(8 up-regulated and 8 down-regulated),11 only in keloid(9 up-regulated and 2 down-regulated) and 9 only in hypertrophic scar(4 up-regulated and 5 down-regulated). CONCLUSION: Proteomic analysis can identify the proteins with va riance of pathological scars versus normal skin,thus providing probable new clu es to reveal the formation mechanism of pathological scars.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第9期1802-1806,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.30973128) 广东省自然科学基金资助项目(No.8151008901000082) 广东省自然科学基金资助项目(No.2007B031504003)
关键词 瘢痕疙瘩 瘢痕 增生性 蛋白质组学 波形蛋白 Asporin OSTEOGLYCIN Keloid Scars hypertrophic Proteomics Vimen tin Asporin Osteoglycin
  • 相关文献

参考文献12

  • 1Namazi MR,Fallahzadeh MK,Schwartz RA.Strategies for prevention of scars:what can we learn from fetal skin?[J].Int J Dermatol,2011,50(1):85-93.
  • 2Ogawa R.The most current algorithms for the treatment and prevention of hypertrophic scars and keloids[J].Plast Reconstr Surg,2010,125(2):557-568.
  • 3沈静,杨军,余应年.质谱技术在蛋白质组学中的应用[J].中国病理生理杂志,2005,21(10):2057-2061. 被引量:2
  • 4Kou I,Nakajima M,Ikegawa S.Expression and regulation of the osteoarthritis-associated protein asporin[J].J Biol Chem,2007,282(44):32193-32199.
  • 5唐冰,朱斌,毕良宽,薛春利,蔡浩,朱家源.瘢痕疙瘩中Smads表达的研究[J].中华外科杂志,2009,47(12):941-943. 被引量:7
  • 6McEwan PA,Scott PG,Bishop PN,et al.Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans[J].J Struct Biol,2006,155(2):294-305.
  • 7Ge GX,Seo NS,Liang XW,et al.Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis[J].J Biol Chem,2004,279(40):41626-41633.
  • 8Tasheva ES,Koester A,Paulsen AQ,et al.Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities[J].Mol Vis,2002,8:407-415.
  • 9李圣青,简文,遆新宇,刘阿茹,阙海萍,杨树广.急性肺栓塞后osteoglycin的表达及对胶原代谢的影响[J].解放军医学杂志,2007,32(1):29-31. 被引量:2
  • 10王珍祥,吴军,易绍萱.波形蛋白在增生性瘢痕中表达与作用的研究[J].中华医学美学美容杂志,2003,9(5):293-295. 被引量:12

二级参考文献47

  • 1李圣青,赵峰,戚好文,张晓君,赵馨,潘刚,吴哲,王宇,阙海萍,刘少君.肺组织灌注前后双向电泳的比较[J].西安交通大学学报(医学版),2006,27(2):203-206. 被引量:12
  • 2Hui Zheng Lili Li Duosha Hu Xiyun Deng Ya Cao.Role of Epstein-Barr Virus Encoded Latent Membrane Protein 1 in the Carcinogenesis of Nasopharyngeal Carcinoma[J].Cellular & Molecular Immunology,2007,4(3):185-196. 被引量:34
  • 3Ogawa R. Keloids as a serious disease such as malignancy. Plast Recortstr Surg, 2008, 122:993-994.
  • 4Robles DT, Moore E, Draznin M, et al. Keloids: pathophysiology and management. Dermatol Online J, 2007, 13:9.
  • 5Jagadeesan J, Bayat A. Transforming growth factor beta (TGFbeta) and keloid disease. Int J Surg, 2007, 5:278-285.
  • 6Bock O, Yu H, Zitron S, et al. Studies of transforming growth factors beta 1-3 and their receptors Ⅰ and Ⅱ in fibroblast of keloids and hypertrophic scars. Acta Derm Venereol, 2005, 85: 216 -220.
  • 7Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrance to the nucleus. Cell, 2003, 113:685-700.
  • 8Kopp J, Preis E, Said H, et al. Abrogation of transforming growth factor-beta signaling by SMAD7 inhibits collagen gel contraction of human dermal fibroblasts. J Biol Chem, 2005, 280: 21570- 21576.
  • 9李宏武,姚克,金红颖,孙丽霞.人晶状体上皮细胞蛋白质组的双向电泳和质谱鉴定[J].中国病理生理杂志,2007,23(8):1598-1601. 被引量:3
  • 10Medzihradszky KF,Campbell JM,Baldwin MA,et al. The characteristics of peptide collision-induced dissociation using a high-performance MALDI-TOF/TOF tandem mass spectrometer[J]. Anal Chem,2000,72(3):552-558.

共引文献26

同被引文献77

  • 1Jennifer M.Hahn,Kevin L.McFarland,Kelly A.Combs,Dorothy M.Supp.Partial epithelial-mesenchymal transition in keloid scars: regulation of keloid keratinocyte gene expression by transforming growth factor-β1[J].Burns & Trauma,2016,4(3):199-215. 被引量:19
  • 2潘运刚.蛋白质组学研究进展[J].赤峰学院学报(自然科学版),2005,21(6):48-49. 被引量:6
  • 3李蔚勃,曹佩华,曹峻岭.α-2巨球蛋白对骨关节炎的影响[J].国外医学(医学地理分册),2006,27(1):1-5. 被引量:7
  • 4骨关节炎诊治指南(2007年版)[J].中华骨科杂志,2007,27(10):793-796. 被引量:1964
  • 5Guccione AA, Felson DT, Anderson J J, et al. The effects of specific medical conditions on the functional limitations of elders in the framingham study [ J ]. Am J Public Health, 1994,84 ( 3 ) :351 - 358.
  • 6Dodds AW, Law SK. The phylogeny and evolution of the thioester bond - containing proteins C3, CA and α2 - macroglobulin [ J ]. Immunol Rev, 1998, 166 : 15 - 26.
  • 7Mocchegiani E, Ciavattini A, Santarelli L, et al. Role of zinc and α2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency( natural killer activity and interleukin - 2 in cervical carcinoma [ J ]. Br J Cancer, 1999,79 ( 2 ): 244 - 250.
  • 8Singleton AB, Gibson AM, McKeith IG, et al. α2 - Macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies[J]. Neuroreport, 1999,10(7) : 1507 - 1510.
  • 9Rudrasingham V, Warrant - De Vrieze F, Lambert JC, et al. α- 2 macroglobulin gene and Alzheimer disease [ J ]. Nat Genet, 1999,22 ( 1 ) : 17 - 19.
  • 10Tortorella MD, Arner EC, Hills R, et al. α2 - Macro- globulin is a novel substrate for ADAMTS - 4 and AD- AMTS -5 and represents an endogenous inhibitor of these enzymes [ J ]. J Biol Chem, 2004, 279 ( 17 ) : 17554 - 17561.

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部